Pre-Eclampsia: all 904 studies
Page 8 of 10. Open to participants first (241), then studies with results posted, then the rest; newest registration first within each.
- User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot StudyCompletedNCT02384226
- Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and MexicoCompletedNCT02381210
- Longitudinal Study: Diagnosis and Prediction of Pre-Eclampsia by Using Congo Red Dot Test in Bangladesh and MexicoStatus unknownNCT02381197
- Pre-Eclampsia And Growth Restriction: a Longitudinal StudyCompletedNCT02379832
- First Trimester Prediction of Preeclampsia and Fetal Growth RestrictionCompletedNCT02379494
- Role of Placental Growth Factor (PlGF) in the Management of Non-Severe PreeclampsiaStatus unknownNCT02373839Not applicable
- Efficacy and Safety of L Arginine to Prevent PreeclampsiaCompletedNCT02363348Phase 3
- The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE StudyCompletedNCT02357667
- Microcirculatory and Tissue and Cerebral Oxygenation in Preeclampsia and Normal Pregnancy: An Observation StudyWithdrawnNCT02351583
- Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsiaCompletedNCT02350036
- Low Dose Calcium to Prevent PreeclampsiaCompletedNCT02338687Phase 4
- Preeclampsia Subtypes and Surrogate Markers of CVD RiskStatus unknownNCT02337049
- A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation DisordersStatus unknownNCT02336243Phase 3
- Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot StudyCompletedNCT02333240Not applicable
- Magnesium Sulfate in Pregnancy and PostpartumCompletedNCT02317146Phase 2/3
- Rosuvastatin in Order to Induce Preeclampsia Resolution in Severe PET up to 48 Hours Following DeliveryStatus unknownNCT02314286Phase 1/2
- Magnesium Sulfate During the Postpartum in Women With Severe PreeclampsiaCompletedNCT02307201Phase 2/3
- Determining the Risk Elevation After MaternityStatus unknownNCT02305745
- CPAP in PreeclampsiaTerminatedNCT02303834Not applicable
- Combined Multi-marker Screening and Treatment With Aspirin for Pre-eclampsia PreventionCompletedNCT02301780Phase 3
- Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe PreeclampsiaTerminatedNCT02286284Phase 2
- Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial.CompletedNCT02280031Phase 2
- Atenativ Effect on Uterine Blood Flow and PreeclampsiaWithdrawnNCT02278575Phase 4
- uChek Pilot Study for Urinalysis in the Antenatal Care SettingStatus unknownNCT02256995
- Pancreatic Stone Protein (PSP) in Pregnant WomenStatus unknownNCT02247297
- Ephedrine, Phenylephrine and Metaraminol Effects on Maternal Cardiac Output, Uterine Blood Flow and Fetal CirculationStatus unknownNCT02245191Not applicable
- Cornell University-Micronutrient Initiative Calcium Supplementation StudyCompletedNCT02238704Not applicable
- Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)CompletedNCT02221830Early Phase 1
- ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy OutcomesCompletedNCT02218931Not applicable
- First-trimester Prediction of PreeclampsiaCompletedNCT02189148
- Postprandial Walking in Obese Pregnant Women and Perinatal Outcomes - a Multicenter Randomized Clinical TrialWithdrawnNCT02180152Not applicable
- Prevention of Preeclampsia With Aspirin in Recipients of Donated Oocytes.TerminatedNCT02174328Phase 3
- Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl ApproachCompletedNCT02164370
- Diuretics for Postpartum High Blood Pressure in PreeclampsiaCompletedNCT02163655Phase 4
- Preeclampsia and Circulating BiomarkersStatus unknownNCT02136667
- A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate RegimenCompletedNCT02091401Phase 4
- Prevention of Postpartum Hemorrhage in Patients With Severe Preeclampsia Using Carbetocin Versus MisoprostolCompletedNCT02086994Phase 3
- Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.CompletedNCT02050529Phase 2
- The Expression of Aquaporin 3, 8 and 9 in Placenta in Normal and Preeclamptic Pregnancies: Perinatal and Neonatal Outcomes.Status unknownNCT02045316
- Establishing First Trimester Markers for the Identification of High Risk TwinStatus unknownNCT02031393
- Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia TrialStatus unknownNCT02007837Phase 3
- Nonsteroidal Antiinflammatory Drugs in Women With Postpartum Pre-eclampsiaCompletedNCT01988298Phase 2/3
- Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid ApheresisCompletedNCT01967355Not applicable
- Extracellular Matrix Remodeling of the Umbilical Cord and Placenta in PreeclampsiaStatus unknownNCT01931891
- Evaluation of a Physical Therapy Protocol on Quality of Life Musculoskeletal Pain and Anxiety in Women With PreeclampsiaCompletedNCT01925508
- Micro Array Analysis in PreeclampsiaStatus unknownNCT01914809Not applicable
- Oral Antihypertensive Regimens for Management of Hypertension in PregnancyCompletedNCT01912677Phase 4
- Community Level Interventions for Pre-eclampsiaCompletedNCT01911494Not applicable
- Circulating Oxidative Stress and Gestational Hypertension. Study of the Evolution of Free-radical Markers of Oxidative Stress From Before to After Childbirth in Two Groups of Women: Normal Pregnancy and Pre-eclampsia.CompletedNCT01907620Not applicable
- İs There a Relationship Between Severity of Preeclampsia and Maternal Heavy Metal Levels?Status unknownNCT01906567
- IMproved PRegnancy Outcome by Early DetectionStatus unknownNCT01891240
- Low Dose Aspirin for the Prevention of PreeclampsiaStatus unknownNCT01890005Phase 3
- The Effect of Prematurity and Hypertensive Disorders of Pregnancy on Offspring Cardiovascular HealthStatus unknownNCT01888770
- Standard 24-hour Urine Protein vs Shorter Period for Diagnosis of Pre-eclampsiaCompletedNCT01881542
- Increased Salt Sensitivity of Ambulatory Blood Pressure in Women With a History of Severe PreeclampsiaCompletedNCT01874990Not applicable
- A Skills and Drills Intervention for Emergency Obstetrics and Neonatal Care at First Referral Units of North KarnatakaCompletedNCT01865656Not applicable
- Evaluation of Educational Tools for Pregnant WomenCompletedNCT01858324Not applicable
- The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- EclampsiaStatus unknownNCT01856387
- New Magnesium Sulphate Protocol for Pre-eclampsiaCompletedNCT01846156Phase 3
- Hypertension and Urine Protease Activity in PreeclampsiaCompletedNCT01828138Not applicable
- Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes MellitusCompletedNCT01821053
- Calcium Supplementation to Prevent Preeclampsia in Sichuan Province of ChinaStatus unknownNCT01806454Not applicable
- Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of ChinaStatus unknownNCT01804751
- Induction With Foley OR Misoprostol (INFORM) StudyCompletedNCT01801410Phase 3
- Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean DeliveryCompletedNCT01766089Phase 2
- Clonidine Versus Captopril for Treatment of Postpartum Very High Blood PressureCompletedNCT01761916Phase 4
- Free DNA and Nucleosome Concentrations in Pathological PregnanciesCompletedNCT01736826
- Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery DopplersCompletedNCT01729468Phase 4
- Pravastatin for Prevention of PreeclampsiaCompletedNCT01717586Phase 1
- Epigenomic Dysregulation in Preeclampsia-Associated Chronic HypertensionCompletedNCT01682304
- Effect of Methyldopa on Uterine Artery Diameter in Pregnant Women With Mild PreeclampsiaCompletedNCT01674127Phase 2
- Placental Growth and Adverse Pregnancy OutcomesCompletedNCT01669525
- Assessing Childbirth-related Complications at the Community Level in KenyaCompletedNCT01665456
- Longitudinal Measures of Leptin in Pregnant Women Who Developed PreeclampsiaCompletedNCT01649167
- Screening for Preeclampsia With Various Markers in Low-risk Pregnancy PopulationsCompletedNCT01649128
- Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm NewbornCompletedNCT01648855
- Vitamin D and PreeclampsiaCompletedNCT01648842
- Physical Therapy in Pregnant Women With PreeclampsiaStatus unknownNCT01630772Phase 1/2
- Random Urine Protein-creatinin Ratio to Predict Magnitude of ProteinuriaStatus unknownNCT01623791
- A Modernized Approach to Prenatal Care in Low Risk WomenCompletedNCT01606774Not applicable
- Restless Leg Syndrome and Severe PreeclampsiaCompletedNCT01538147
- Antiphospholipid Antibodies and Early Severe Preeclampsia.Status unknownNCT01538121
- ST- Depression on Electrocardiogram During Caesarean Section in Regional Anaesthesia in Women With PreeclampsiaCompletedNCT01530230Not applicable
- Preeclampsia: A Marker for Future Cardiovascular Risk in WomenSuspendedNCT01519297Not applicable
- Progesterone for First Trimester Vaginal BleedingWithdrawnNCT01501890Not applicable
- EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth RestrictionCompletedNCT01490489Not applicable
- Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)CompletedNCT01480544Not applicable
- Maternal and Neonatal Outcomes of the Use of Vasopressors to Treat Hypotension During Spinal Anesthesia for CesareanWithdrawnNCT01451060Phase 3
- Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of PreeclampsiaCompletedNCT01447290
- Consumption of Chocolate in Pregnant Women.CompletedNCT01431443Phase 2
- Effectiveness Study of Short Course of Magnesium Sulfate for Severe PreeclamsiaCompletedNCT01408979Phase 4
- Removal of Anti-Angiogenic Proteins in Preeclampsia Before DeliveryCompletedNCT01404910Not applicable
- Assessment of Physical Exercise Using Stationary Bicycle for Pregnant Women With Risk for Preeclampsia DevelopmentCompletedNCT01395342Phase 1
- Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancyCompletedNCT01388322Phase 3
- Inflammatory Markers in Pregnant Women Destined to Develop PreeclampsiaCompletedNCT01388283
- Detecting Early Onset Pre-eclampsia and Use of Placental Growth Factor (PlGF) for Marker of Trisomy 21TerminatedNCT01387776
- Inflammatory Markers in PreeclampsiaCompletedNCT01385813
- Carbetocin vs. Oxytocin for Prevention of Postpartum Bleeding in Patients With Severe PreeclampsiaStatus unknownNCT01382732Phase 3
- Hypertensive Disorders of Pregnancy in Adolescence and PrimipaternityStatus unknownNCT01374477
- Serum Markers in Preeclamptic WomenCompletedNCT01361737